Cargando…

Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study

OBJECTIVE: To examine the interactive relationship between diabetic retinopathy (DR) and diabetic nephropathy (DN) in type 2 diabetic patients and to elucidate the role of DR and microalbuminuria on the onset of macroalbuminuria and renal function decline. RESEARCH DESIGN AND METHODS: We explored th...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriya, Tatsumi, Tanaka, Shiro, Kawasaki, Ryo, Ohashi, Yasuo, Akanuma, Yasuo, Yamada, Nobuhiro, Sone, Hirohito, Yamashita, Hidetoshi, Katayama, Shigehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747927/
https://www.ncbi.nlm.nih.gov/pubmed/23620478
http://dx.doi.org/10.2337/dc12-2327
_version_ 1782281005928808448
author Moriya, Tatsumi
Tanaka, Shiro
Kawasaki, Ryo
Ohashi, Yasuo
Akanuma, Yasuo
Yamada, Nobuhiro
Sone, Hirohito
Yamashita, Hidetoshi
Katayama, Shigehiro
author_facet Moriya, Tatsumi
Tanaka, Shiro
Kawasaki, Ryo
Ohashi, Yasuo
Akanuma, Yasuo
Yamada, Nobuhiro
Sone, Hirohito
Yamashita, Hidetoshi
Katayama, Shigehiro
author_sort Moriya, Tatsumi
collection PubMed
description OBJECTIVE: To examine the interactive relationship between diabetic retinopathy (DR) and diabetic nephropathy (DN) in type 2 diabetic patients and to elucidate the role of DR and microalbuminuria on the onset of macroalbuminuria and renal function decline. RESEARCH DESIGN AND METHODS: We explored the effects of DR and microalbuminuria on the progression of DN from normoalbuminuria and low microalbuminuria (<150 mg/gCr) to macroalbuminuria or renal function decline in the Japan Diabetes Complications Study (JDCS), which is a nationwide randomized controlled study of type 2 diabetic patients focusing on lifestyle modification. Patients were divided into four groups according to presence or absence of DR and MA: normoalbuminuria without DR [NA(DR−)] (n = 773), normoalbuminuria with DR [NA(DR+)] (n = 279), microalbuminuria without DR [MA(DR−)] (n = 277), and microalbuminuria with DR [MA(DR+)] (n = 146). Basal urinary albumin-to-creatinine ratio and DR status were determined at baseline and followed for a median of 8.0 years. RESULTS: Annual incidence rates of macroalbuminuria were 1.6/1,000 person-years (9 incidences), 3.9/1,000 person-years (8 incidences), 18.4/1,000 person-years (34 incidences), and 22.1/1,000 person-years (22 incidences) in the four groups, respectively. Multivariate-adjusted hazard ratios of the progression to macroalbuminuria were 2.48 (95% CI 0.94–6.50; P = 0.07), 10.40 (4.91–22.03; P < 0.01), and 11.55 (5.24–25.45; P < 0.01) in NA(DR+), MA(DR−), and MA(DR+), respectively, in comparison with NA(DR−). Decline in estimated glomerular filtration rate (GFR) per year was two to three times faster in MA(DR+) (−1.92 mL/min/1.73 m(2)/year) than in the other groups. CONCLUSIONS: In normo- and low microalbuminuric Japanese type 2 diabetic patients, presence of microalbuminuria at baseline was associated with higher risk of macroalbuminuria in 8 years. Patients with microalbuminuria and DR showed the fastest GFR decline. Albuminuria and DR should be considered as risk factors of renal prognosis in type 2 diabetic patients. An open sharing of information will benefit both ophthalmologists and diabetologists.
format Online
Article
Text
id pubmed-3747927
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-37479272014-09-01 Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study Moriya, Tatsumi Tanaka, Shiro Kawasaki, Ryo Ohashi, Yasuo Akanuma, Yasuo Yamada, Nobuhiro Sone, Hirohito Yamashita, Hidetoshi Katayama, Shigehiro Diabetes Care Original Research OBJECTIVE: To examine the interactive relationship between diabetic retinopathy (DR) and diabetic nephropathy (DN) in type 2 diabetic patients and to elucidate the role of DR and microalbuminuria on the onset of macroalbuminuria and renal function decline. RESEARCH DESIGN AND METHODS: We explored the effects of DR and microalbuminuria on the progression of DN from normoalbuminuria and low microalbuminuria (<150 mg/gCr) to macroalbuminuria or renal function decline in the Japan Diabetes Complications Study (JDCS), which is a nationwide randomized controlled study of type 2 diabetic patients focusing on lifestyle modification. Patients were divided into four groups according to presence or absence of DR and MA: normoalbuminuria without DR [NA(DR−)] (n = 773), normoalbuminuria with DR [NA(DR+)] (n = 279), microalbuminuria without DR [MA(DR−)] (n = 277), and microalbuminuria with DR [MA(DR+)] (n = 146). Basal urinary albumin-to-creatinine ratio and DR status were determined at baseline and followed for a median of 8.0 years. RESULTS: Annual incidence rates of macroalbuminuria were 1.6/1,000 person-years (9 incidences), 3.9/1,000 person-years (8 incidences), 18.4/1,000 person-years (34 incidences), and 22.1/1,000 person-years (22 incidences) in the four groups, respectively. Multivariate-adjusted hazard ratios of the progression to macroalbuminuria were 2.48 (95% CI 0.94–6.50; P = 0.07), 10.40 (4.91–22.03; P < 0.01), and 11.55 (5.24–25.45; P < 0.01) in NA(DR+), MA(DR−), and MA(DR+), respectively, in comparison with NA(DR−). Decline in estimated glomerular filtration rate (GFR) per year was two to three times faster in MA(DR+) (−1.92 mL/min/1.73 m(2)/year) than in the other groups. CONCLUSIONS: In normo- and low microalbuminuric Japanese type 2 diabetic patients, presence of microalbuminuria at baseline was associated with higher risk of macroalbuminuria in 8 years. Patients with microalbuminuria and DR showed the fastest GFR decline. Albuminuria and DR should be considered as risk factors of renal prognosis in type 2 diabetic patients. An open sharing of information will benefit both ophthalmologists and diabetologists. American Diabetes Association 2013-09 2013-08-13 /pmc/articles/PMC3747927/ /pubmed/23620478 http://dx.doi.org/10.2337/dc12-2327 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Moriya, Tatsumi
Tanaka, Shiro
Kawasaki, Ryo
Ohashi, Yasuo
Akanuma, Yasuo
Yamada, Nobuhiro
Sone, Hirohito
Yamashita, Hidetoshi
Katayama, Shigehiro
Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
title Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
title_full Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
title_fullStr Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
title_full_unstemmed Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
title_short Diabetic Retinopathy and Microalbuminuria Can Predict Macroalbuminuria and Renal Function Decline in Japanese Type 2 Diabetic Patients: Japan Diabetes Complications Study
title_sort diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in japanese type 2 diabetic patients: japan diabetes complications study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747927/
https://www.ncbi.nlm.nih.gov/pubmed/23620478
http://dx.doi.org/10.2337/dc12-2327
work_keys_str_mv AT moriyatatsumi diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT tanakashiro diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT kawasakiryo diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT ohashiyasuo diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT akanumayasuo diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT yamadanobuhiro diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT sonehirohito diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT yamashitahidetoshi diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT katayamashigehiro diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy
AT diabeticretinopathyandmicroalbuminuriacanpredictmacroalbuminuriaandrenalfunctiondeclineinjapanesetype2diabeticpatientsjapandiabetescomplicationsstudy